Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
16.53
-0.17 (-1.02%)
May 15, 2025, 2:21 PM - Market open
Apellis Pharmaceuticals Analyst Ratings
Total Analysts
19
Consensus Rating
Buy
Price Target
$38.06
Upside
+130.25%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Hold Maintains $30 → $20 | Hold | Maintains | $30 → $20 | +20.99% | May 14, 2025 |
| Raymond James | Raymond James | Strong Buy → Buy Downgrades $75 → $52 | Strong Buy → Buy | Downgrades | $75 → $52 | +214.58% | May 9, 2025 |
| B of A Securities | B of A Securities | Strong Buy → Hold Downgrades $41 → $23 | Strong Buy → Hold | Downgrades | $41 → $23 | +39.14% | May 9, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $21 → $18 | Hold | Maintains | $21 → $18 | +8.89% | May 8, 2025 |
| Scotiabank | Scotiabank | Hold Maintains $28 → $20 | Hold | Maintains | $28 → $20 | +20.99% | May 8, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $30 → $26 | Hold | Maintains | $30 → $26 | +57.29% | May 8, 2025 |
| Baird | Baird | Buy Maintains $55 → $47 | Buy | Maintains | $55 → $47 | +184.33% | May 8, 2025 |
| Needham | Needham | Strong Buy Maintains $40 → $29 | Strong Buy | Maintains | $40 → $29 | +75.44% | May 7, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $44 | Buy | Initiates | $44 | +166.18% | Apr 29, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $24 → $21 | Hold | Maintains | $24 → $21 | +27.04% | Apr 21, 2025 |
| Scotiabank | Scotiabank | Hold Maintains $30 → $31 | Hold | Maintains | $30 → $31 | +87.54% | Apr 2, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $50 → $54 | Buy | Maintains | $50 → $54 | +226.68% | Mar 4, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $26 → $25 | Hold | Maintains | $26 → $25 | +51.24% | Mar 3, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $36 → $32 | Hold | Maintains | $36 → $32 | +93.59% | Mar 3, 2025 |
| Wedbush | Wedbush | Hold Maintains $30 → $29 | Hold | Maintains | $30 → $29 | +75.44% | Mar 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $57 | Strong Buy | Reiterates | $57 | +244.83% | Mar 3, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.